AIxCrypto Holdings Inc Dossier
|
SectorInformation Technology IndustrySystems Software Beta (adjusted)1.00 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $1.01Price as of 29 Sep 2026 Data confidenceNot applicable Market Cap $21.3M Enterprise Value $15.1M Shares Outstanding 20.1M diluted Next Earnings Date12 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary AIxCrypto Holdings, Inc. (formerly Qualigen Therapeutics, Inc.) completed a transformational strategic pivot in late 2025, rebranding and shifting its business model from biotechnology to an ecosystem integrating Artificial Intelligence and blockchain technology. While the company has shown rapid initial user traction on its flagship AIxC Hub platform (surpassing 5.8 million registered wallets and 1.3 million daily active participants as of March 2026), it remains a pre-revenue enterprise with substantial liquidity risks. The company's financial sustainability is heavily dependent on the successful execution of its three planned 2026 revenue rails: Physical AI infrastructure (EAI Data Platform), AI Agent products, and Real-World Asset (RWA) equity tokenization. Given the ongoing cash burn, substantial doubt regarding its ability to continue as a going concern, and highly concentrated investment exposure to Faraday Future Intelligent Electric Inc. (FFAI), a cautious 'Hold' is recommended until initial product delivery and revenue generation materialize. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario The company fails to generate meaningful revenue from its AI and blockchain initiatives in 2026, leading to rapid cash depletion. Regulatory hurdles delay or block the launch of the RWA equity tokenization platform. Severe valuation declines or bankruptcy events at Faraday Future write down the company's concentrated $12 million investment, and the going-concern uncertainty results in severe dilution or delisting from the Nasdaq Capital Market. Base CaseCentral scenario The company successfully transitions from its foundational phase to initial product delivery and revenue generation across its three core rails in the second half of 2026. The $50 million equity purchase facility with Gold King Arthur Holding Limited provides sufficient runway to normalize operating expenses and mitigate going-concern risks. The Faraday Future RWA tokenization proof-of-concept launches successfully, establishing a compliant on-chain infrastructure for tokenized equity. Bull CaseUpside scenario Successful execution of the RWA tokenization product line using Faraday Future equity as a proof of concept, combined with rapid scaling of the EAI data platform and AIxC Hub to drive transaction-based revenue and achieve operating leverage. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |